Docosahexaenoic Acid (DHA) for Women With Breast Cancer in the Neoadjuvant Setting

Exclusion Criteria

• •1. Patients undergoing surgery prior to chemotherapy.
• •2. Current or previous (within 2 months) daily use (\>1 day/week) use of omega-3, fish oil, or other supplements or functional foods containing docosahexaenoic acid (at daily doses \> 200 mg).
• •3. Known allergy to soy or corn.
• •4. Continued intake of supplements containing Vitamin C, Vitamin E or β-carotene exceeding the DRI, or other anti-oxidant supplements.
• •5. Symptomatic but untreated cholelithiasis.
• •6. History of deep venous thrombosis, active thrombophlebitis, pulmonary embolism, stroke, acute myocardial infarction, congestive cardiac failure, untreated hypertension, known inherited hypercoagulable disorder.
• •7. Diagnosis of any other malignancy within the previous year except for adequately treated basal cell or squamous cell skin cancer.
• •8. Medically documented history of a psychiatric disorder that would preclude consent
• •9. Partial or complete loss of vision or diplopia, from ophthalmic vascular disease.
• •10. Hypersensitivity to DHA or to any ingredient in the formulation or component of the container.